// App-Quantinova.ai

ISC24 2016 BOS : Improving Door-to-Needle Times in Acute Ischemic Stroke: Interim Findings From Target: Stroke Phase II

Researchers

Presenter

  • Margueritte Cox

Principal Investigators

  • Eric E Smith

  • Lee H Schwamm

  • Jeffrey L Saver

  • Mathew J Reeves

  • Deepak L Bhatt

  • Robert Suter

  • Philip J Schulte

  • Ying Xian

  • Adrian F Hernandez

  • Eric D Peterson

Medical Centers

  • Massachusetts General Hospital, Boston, MA

  • Duke Clinical Research Institute, Durham, NC

  • UCLA Medcl Ctr, Los Angeles, CA

  • Harvard Medical School, Boston, MA

  • Michigan State University, Lansing, MI

  • American Heart Association, El Paso, TX

  • Univ of Calgary, Calgary, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim